mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |